Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 213

1.

Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.

Britschgi C, Riesterer O, Burger IA, Guckenberger M, Curioni-Fontecedro A.

Radiat Oncol. 2018 May 31;13(1):102. doi: 10.1186/s13014-018-1049-3.

2.

PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives.

Zschaeck S, Lohaus F, Beck M, Habl G, Kroeze S, Zamboglou C, Koerber SA, Debus J, Hölscher T, Wust P, Ganswindt U, Baur ADJ, Zöphel K, Cihoric N, Guckenberger M, Combs SE, Grosu AL, Ghadjar P, Belka C.

Radiat Oncol. 2018 May 11;13(1):90. doi: 10.1186/s13014-018-1047-5. Review.

3.

Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria.

Alongi F, Mazzola R, Figlia V, Guckenberger M.

Tumori. 2018 Apr 1:300891618766820. doi: 10.1177/0300891618766820. [Epub ahead of print]

PMID:
29714665
4.

Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.

Finazzi T, Rordorf T, Ikenberg K, Huber GF, Guckenberger M, Garcia Schueler HI.

BMC Cancer. 2018 Apr 6;18(1):395. doi: 10.1186/s12885-018-4295-8.

5.

Perspectives on oligometastasis: challenges and opportunities.

Heitmann J, Guckenberger M.

J Thorac Dis. 2018 Jan;10(1):113-117. doi: 10.21037/jtd.2017.12.77. No abstract available.

6.

Population Description and Clinical Response Assessment for Spinal Metastases: Part 2 of the SPIne Response Assessment in Neuro-Oncology (SPINO) Group Report.

Laufer I, Lo SS, Chang EL, Sheehan J, Guckenberger M, Sohn MJ, Ryu S, Foote M, Muacevic A, Soltys SG, Chao S, Myrehaug S, Gerszten PC, Lis E, Maralani P, Bilsky M, Fisher C, Rhines L, Verlaan JJ, Schiff D, Fehlings MG, Ma L, Chang S, Parelukar WR, Vogelbaum MA, Sahgal A.

Neuro Oncol. 2018 Mar 24. doi: 10.1093/neuonc/noy047. [Epub ahead of print]

PMID:
29590465
7.

Histopathological Findings After Reirradiation Compared to First Irradiation of Spinal Bone Metastases With Stereotactic Body Radiotherapy: A Cohort Study.

Foerster R, Cho BCJ, Fahim DK, Gerszten PC, Flickinger JC, Grills IS, Jawad MS, Kersh CR, Létourneau D, Mantel F, Sahgal A, Shin JH, Winey BA, Guckenberger M.

Neurosurgery. 2018 Mar 14. doi: 10.1093/neuros/nyy059. [Epub ahead of print]

PMID:
29547929
8.

The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.

Andratschke N, Alheid H, Allgäuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S, Guckenberger M, Hildebrandt G, Klement RJ, Lewitzki V, Ostheimer C, Papachristofilou A, Petersen C, Schneider T, Semrau R, Wachter S, Habermehl D.

BMC Cancer. 2018 Mar 13;18(1):283. doi: 10.1186/s12885-018-4191-2.

9.

Influence of inter-observer delineation variability on radiomics stability in different tumor sites.

Pavic M, Bogowicz M, Würms X, Glatz S, Finazzi T, Riesterer O, Roesch J, Rudofsky L, Friess M, Veit-Haibach P, Huellner M, Opitz I, Weder W, Frauenfelder T, Guckenberger M, Tanadini-Lang S.

Acta Oncol. 2018 Mar 7:1-5. doi: 10.1080/0284186X.2018.1445283. [Epub ahead of print]

PMID:
29513054
10.

Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy.

Klement RJ, Hoerner-Rieber J, Adebahr S, Andratschke N, Blanck O, Boda-Heggemann J, Duma M, Eble MJ, Eich HC, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl KH, Klass ND, Krempien R, Lohaus F, Petersen C, Schrade E, Wendt TG, Wittig A, Guckenberger M.

Radiother Oncol. 2018 May;127(2):246-252. doi: 10.1016/j.radonc.2018.02.016. Epub 2018 Mar 3.

PMID:
29510865
11.

Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.

Guckenberger M, Sweeney RA, Hawkins M, Belderbos J, Andratschke N, Ahmed M, Madani I, Mantel F, Steigerwald S, Flentje M.

Cancer. 2018 May 1;124(9):2001-2009. doi: 10.1002/cncr.31294. Epub 2018 Mar 2.

PMID:
29499073
12.

Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study.

Leijenaar RT, Bogowicz M, Jochems A, Hoebers FJ, Wesseling FW, Huang SH, Chan B, Waldron JN, O'Sullivan B, Rietveld D, Leemans CR, Brakenhoff RH, Riesterer O, Tanadini-Lang S, Guckenberger M, Ikenberg K, Lambin P.

Br J Radiol. 2018 Jun;91(1086):20170498. doi: 10.1259/bjr.20170498. Epub 2018 Mar 22.

PMID:
29451412
13.

Exploratory Radiomics in Computed Tomography Perfusion of Prostate Cancer.

Tanadini-Lang S, Bogowicz M, Veit-Haibach P, Huellner M, Pauli C, Shukla V, Guckenberger M, Riesterer O.

Anticancer Res. 2018 Feb;38(2):685-690.

14.

Optimization of combined proton-photon treatments.

Unkelbach J, Bangert M, De Amorim Bernstein K, Andratschke N, Guckenberger M.

Radiother Oncol. 2018 Jan 19. pii: S0167-8140(18)30021-5. doi: 10.1016/j.radonc.2017.12.031. [Epub ahead of print]

PMID:
29370987
15.

Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations.

Nieder C, Gaspar LE, Ruysscher D, Guckenberger M, Mehta MP, Rusthoven CG, Sahgal A, Gkika E.

Strahlenther Onkol. 2018 May;194(5):365-374. doi: 10.1007/s00066-018-1266-6. Epub 2018 Jan 23.

PMID:
29362835
16.

Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study.

Basler L, Andratschke N, Ehrbar S, Guckenberger M, Tanadini-Lang S.

Radiat Oncol. 2018 Jan 22;13(1):10. doi: 10.1186/s13014-018-0952-y.

17.

Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study.

Nguyen TK, Senan S, Bradley JD, Franks K, Giuliani M, Guckenberger M, Landis M, Loo BW Jr, Louie AV, Onishi H, Schmidt H, Timmerman R, Videtic GMM, Palma DA.

Pract Radiat Oncol. 2018 Mar - Apr;8(2):e71-e78. doi: 10.1016/j.prro.2017.10.008. Epub 2017 Dec 30.

PMID:
29291965
18.

Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".

Hoerner-Rieber J, Duma M, Blanck O, Hildebrandt G, Wittig A, Lohaus F, Flentje M, Mantel F, Krempien R, Eble MJ, Kahl KH, Boda-Heggemann J, Rieken S, Guckenberger M.

J Thorac Dis. 2017 Nov;9(11):4512-4522. doi: 10.21037/jtd.2017.10.108.

19.

[Which patients with localized prostate cancer benefit from which local procedure and what does "benefit" mean in prostate cancer?]

Kroeze S, Fritz C, Guckenberger M.

Strahlenther Onkol. 2018 Feb;194(2):174-177. doi: 10.1007/s00066-017-1243-5. German. No abstract available.

PMID:
29264623
20.

NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma.

Weiss T, Weller M, Guckenberger M, Sentman CL, Roth P.

Cancer Res. 2018 Feb 15;78(4):1031-1043. doi: 10.1158/0008-5472.CAN-17-1788. Epub 2017 Dec 8.

PMID:
29222400

Supplemental Content

Loading ...
Support Center